Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0031974 | membrane-enclosed lumen | 2 | 2 |
GO:0031981 | nuclear lumen | 5 | 2 |
GO:0043233 | organelle lumen | 3 | 2 |
GO:0070013 | intracellular organelle lumen | 4 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
Related structures:
AlphaFold database: Q4QG65
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 327 | 331 | PF00656 | 0.592 |
CLV_NRD_NRD_1 | 103 | 105 | PF00675 | 0.530 |
CLV_NRD_NRD_1 | 141 | 143 | PF00675 | 0.549 |
CLV_NRD_NRD_1 | 236 | 238 | PF00675 | 0.506 |
CLV_NRD_NRD_1 | 257 | 259 | PF00675 | 0.497 |
CLV_NRD_NRD_1 | 51 | 53 | PF00675 | 0.585 |
CLV_NRD_NRD_1 | 75 | 77 | PF00675 | 0.559 |
CLV_PCSK_FUR_1 | 234 | 238 | PF00082 | 0.502 |
CLV_PCSK_KEX2_1 | 140 | 142 | PF00082 | 0.605 |
CLV_PCSK_KEX2_1 | 236 | 238 | PF00082 | 0.498 |
CLV_PCSK_KEX2_1 | 257 | 259 | PF00082 | 0.502 |
CLV_PCSK_KEX2_1 | 53 | 55 | PF00082 | 0.533 |
CLV_PCSK_KEX2_1 | 75 | 77 | PF00082 | 0.559 |
CLV_PCSK_PC1ET2_1 | 53 | 55 | PF00082 | 0.533 |
CLV_PCSK_SKI1_1 | 113 | 117 | PF00082 | 0.655 |
CLV_PCSK_SKI1_1 | 304 | 308 | PF00082 | 0.570 |
CLV_Separin_Metazoa | 155 | 159 | PF03568 | 0.596 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.575 |
DOC_CYCLIN_yCln2_LP_2 | 42 | 48 | PF00134 | 0.623 |
DOC_MAPK_MEF2A_6 | 276 | 284 | PF00069 | 0.618 |
DOC_PP4_MxPP_1 | 88 | 91 | PF00568 | 0.474 |
DOC_USP7_MATH_1 | 166 | 170 | PF00917 | 0.602 |
DOC_WW_Pin1_4 | 321 | 326 | PF00397 | 0.584 |
DOC_WW_Pin1_4 | 36 | 41 | PF00397 | 0.615 |
LIG_14-3-3_CanoR_1 | 158 | 168 | PF00244 | 0.620 |
LIG_APCC_ABBAyCdc20_2 | 65 | 71 | PF00400 | 0.430 |
LIG_BRCT_BRCA1_1 | 312 | 316 | PF00533 | 0.568 |
LIG_FHA_1 | 209 | 215 | PF00498 | 0.436 |
LIG_FHA_2 | 149 | 155 | PF00498 | 0.699 |
LIG_LIR_Apic_2 | 6 | 12 | PF02991 | 0.649 |
LIG_LIR_Gen_1 | 131 | 139 | PF02991 | 0.535 |
LIG_LIR_Gen_1 | 189 | 198 | PF02991 | 0.442 |
LIG_LIR_Gen_1 | 202 | 208 | PF02991 | 0.332 |
LIG_LIR_Gen_1 | 313 | 321 | PF02991 | 0.670 |
LIG_LIR_Nem_3 | 131 | 137 | PF02991 | 0.540 |
LIG_LIR_Nem_3 | 189 | 194 | PF02991 | 0.439 |
LIG_LIR_Nem_3 | 202 | 206 | PF02991 | 0.341 |
LIG_LIR_Nem_3 | 313 | 319 | PF02991 | 0.666 |
LIG_LIR_Nem_3 | 62 | 67 | PF02991 | 0.419 |
LIG_LIR_Nem_3 | 71 | 77 | PF02991 | 0.426 |
LIG_SH2_CRK | 9 | 13 | PF00017 | 0.566 |
LIG_SH2_STAP1 | 229 | 233 | PF00017 | 0.503 |
LIG_SH2_STAT3 | 229 | 232 | PF00017 | 0.540 |
LIG_SH2_STAT5 | 191 | 194 | PF00017 | 0.471 |
LIG_SH3_3 | 154 | 160 | PF00018 | 0.756 |
LIG_SH3_3 | 201 | 207 | PF00018 | 0.459 |
LIG_SH3_3 | 34 | 40 | PF00018 | 0.618 |
LIG_TRAF2_1 | 253 | 256 | PF00917 | 0.546 |
LIG_TRAF2_1 | 324 | 327 | PF00917 | 0.652 |
MOD_CK1_1 | 170 | 176 | PF00069 | 0.632 |
MOD_CK1_1 | 310 | 316 | PF00069 | 0.620 |
MOD_CK2_1 | 148 | 154 | PF00069 | 0.696 |
MOD_CK2_1 | 295 | 301 | PF00069 | 0.591 |
MOD_CK2_1 | 321 | 327 | PF00069 | 0.595 |
MOD_GlcNHglycan | 113 | 116 | PF01048 | 0.626 |
MOD_GlcNHglycan | 16 | 20 | PF01048 | 0.613 |
MOD_GlcNHglycan | 24 | 27 | PF01048 | 0.589 |
MOD_GlcNHglycan | 271 | 274 | PF01048 | 0.435 |
MOD_GlcNHglycan | 295 | 300 | PF01048 | 0.671 |
MOD_GSK3_1 | 107 | 114 | PF00069 | 0.583 |
MOD_GSK3_1 | 11 | 18 | PF00069 | 0.638 |
MOD_GSK3_1 | 166 | 173 | PF00069 | 0.637 |
MOD_GSK3_1 | 306 | 313 | PF00069 | 0.691 |
MOD_NEK2_1 | 208 | 213 | PF00069 | 0.452 |
MOD_NEK2_1 | 307 | 312 | PF00069 | 0.614 |
MOD_PIKK_1 | 107 | 113 | PF00454 | 0.474 |
MOD_PIKK_1 | 228 | 234 | PF00454 | 0.547 |
MOD_PKA_1 | 236 | 242 | PF00069 | 0.552 |
MOD_PKA_2 | 236 | 242 | PF00069 | 0.470 |
MOD_PKB_1 | 140 | 148 | PF00069 | 0.585 |
MOD_PKB_1 | 234 | 242 | PF00069 | 0.551 |
MOD_Plk_1 | 208 | 214 | PF00069 | 0.501 |
MOD_Plk_2-3 | 57 | 63 | PF00069 | 0.368 |
MOD_Plk_4 | 187 | 193 | PF00069 | 0.455 |
MOD_Plk_4 | 199 | 205 | PF00069 | 0.428 |
MOD_ProDKin_1 | 321 | 327 | PF00069 | 0.583 |
MOD_ProDKin_1 | 36 | 42 | PF00069 | 0.617 |
MOD_SUMO_for_1 | 289 | 292 | PF00179 | 0.580 |
MOD_SUMO_rev_2 | 296 | 306 | PF00179 | 0.731 |
TRG_AP2beta_CARGO_1 | 131 | 141 | PF09066 | 0.594 |
TRG_DiLeu_BaEn_1 | 265 | 270 | PF01217 | 0.521 |
TRG_DiLeu_BaLyEn_6 | 190 | 195 | PF01217 | 0.471 |
TRG_DiLeu_BaLyEn_6 | 210 | 215 | PF01217 | 0.334 |
TRG_ENDOCYTIC_2 | 191 | 194 | PF00928 | 0.458 |
TRG_ER_diArg_1 | 140 | 142 | PF00400 | 0.522 |
TRG_ER_diArg_1 | 233 | 236 | PF00400 | 0.546 |
TRG_ER_diArg_1 | 257 | 259 | PF00400 | 0.547 |
TRG_ER_diArg_1 | 74 | 76 | PF00400 | 0.546 |
TRG_ER_diArg_1 | 98 | 101 | PF00400 | 0.507 |
TRG_NLS_MonoExtC_3 | 51 | 56 | PF00514 | 0.524 |
TRG_Pf-PMV_PEXEL_1 | 193 | 197 | PF00026 | 0.465 |
TRG_Pf-PMV_PEXEL_1 | 242 | 246 | PF00026 | 0.497 |
TRG_Pf-PMV_PEXEL_1 | 257 | 262 | PF00026 | 0.546 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I2K8 | Leptomonas seymouri | 55% | 90% |
A0A0S4IK25 | Bodo saltans | 28% | 83% |
A0A1X0NN31 | Trypanosomatidae | 42% | 100% |
A0A3S7WSI8 | Leishmania donovani | 91% | 100% |
A4H777 | Leishmania braziliensis | 74% | 100% |
A4HVL7 | Leishmania infantum | 91% | 100% |
D0A6N8 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 40% | 100% |
E9APB3 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 89% | 100% |
V5BK51 | Trypanosoma cruzi | 43% | 100% |